Contact PR

To use this feature, join Babbler easily !


Babbler allows PR people and reporters to collaborate a better way.

By joining Babbler you will be able to access hundreds of newsrooms and PR contacts from your industrie(s) and also share with them your upcoming needs.

Their newsrooms are already on Babbler

You're 1 click away from signing up


Nice to see you again !

Press release

Sasa Leskovsek joins the Ethypharm Group as Chief Scientific Officer
timer minutes reading time minute reading time

Copy link

Click to get original image size

St-Cloud, France March 18 2019 The Ethypharm Group is delighted to announce the appointment of Sasa Leskovsek to the Ethypharm Group as Chief Scientific Officer. As such he joins the Group’s Executive Committee.

Sasa, 50, has a PhD from the University of Ljubljana and a MBA from IEDC Bled School of Management. With more than 20 years’ experience in pharmaceutical and R&D organisations, Sasa has worked as advisor for leading investment funds, multinational professional service firms and pharma/biotech companies.

In his capacity as Business Development Director he helped build Walmark, a European based consumer healthcare company and founded City Medical Center, a family medical centre located in Lithuania.

From 2010 to 2015 Sasa was the Head of International Pharma Development in Sanofi building global product development strategy, operating worldwide.

Bertrand DELUARD CEO of Group Ethypharm - commented: Sasa has an excellent and specialized knowledge of the pharmaceutical industry needed to enrich our R&D product portfolio in accordance with the Ethypharm Specialty Strategy in our 3 key therapeutic areas: pain, addiction and critical care.

"Our R&D team is focusing on speciality care and innovation

with ambition to build valuable and sustainable portfolio to meet our patient’s needs in the areas of Pain management, Addiction drugs and Critical Care", added

Sasa LESKOVSEK- Director of Scientific Affairs of Group Ethypharm.

inscrit avec succès

Congratulations, you're registered on Babbler!

Discover now all the news waiting for you on Babbler: visit your newsfeed.!

Your topics have been selected, you can change it by clicking here